The first biotechnology product.

PositionHealth Beat - Food and Drug Administration approves Omalizumab for treatment of asthma - Brief Article

The first biotechnology product to treat patients with a type of asthma that is related to allergies has been approved by the Food and Drug Administration. Omalizumab is a monoclonal antibody shown to be effective in treating people 12 years of age and older with moderate to severe allergy-related asthma inadequately...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT